866-997-4948(US-Canada Toll Free)

United States Anti-Migraine Drugs Market Report 2017

Published By :

QYResearch

Published Date : Aug 2017

Category :

Pharmaceutical

No. of Pages : 111 Pages

In this report, the United States Anti-Migraine Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Anti-Migraine Drugs in these regions, from 2012 to 2022 (forecast).

United States Anti-Migraine Drugs market competition by top manufacturers/players, with Anti-Migraine Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Eli Lilly
Abbott Laboratories
Eisai
Allergan
Endo
GlaxoSmithKline
Impax Laboratories
Pfizer
AstraZeneca
Bayer
Johnson & Johnson
Merck
Teva
Allergan
Amgen

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Triptans
Ergots
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Anti-Migraine Drugs for each application, including
Women
Men

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

United States Anti-Migraine Drugs Market Report 2017
1 Anti-Migraine Drugs Overview
1.1 Product Overview and Scope of Anti-Migraine Drugs
1.2 Classification of Anti-Migraine Drugs by Product Category
1.2.1 United States Anti-Migraine Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Anti-Migraine Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Triptans
1.2.4 Ergots
1.2.5 Others
1.3 United States Anti-Migraine Drugs Market by Application/End Users
1.3.1 United States Anti-Migraine Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Women
1.3.3 Men
1.4 United States Anti-Migraine Drugs Market by Region
1.4.1 United States Anti-Migraine Drugs Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Anti-Migraine Drugs Status and Prospect (2012-2022)
1.4.3 Southwest Anti-Migraine Drugs Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Anti-Migraine Drugs Status and Prospect (2012-2022)
1.4.5 New England Anti-Migraine Drugs Status and Prospect (2012-2022)
1.4.6 The South Anti-Migraine Drugs Status and Prospect (2012-2022)
1.4.7 The Midwest Anti-Migraine Drugs Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Anti-Migraine Drugs (2012-2022)
1.5.1 United States Anti-Migraine Drugs Sales and Growth Rate (2012-2022)
1.5.2 United States Anti-Migraine Drugs Revenue and Growth Rate (2012-2022)

2 United States Anti-Migraine Drugs Market Competition by Players/Suppliers
2.1 United States Anti-Migraine Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Anti-Migraine Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Anti-Migraine Drugs Average Price by Players/Suppliers (2012-2017)
2.4 United States Anti-Migraine Drugs Market Competitive Situation and Trends
2.4.1 United States Anti-Migraine Drugs Market Concentration Rate
2.4.2 United States Anti-Migraine Drugs Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Anti-Migraine Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 United States Anti-Migraine Drugs Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Anti-Migraine Drugs Sales and Market Share by Region (2012-2017)
3.2 United States Anti-Migraine Drugs Revenue and Market Share by Region (2012-2017)
3.3 United States Anti-Migraine Drugs Price by Region (2012-2017)

4 United States Anti-Migraine Drugs Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Anti-Migraine Drugs Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Anti-Migraine Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Anti-Migraine Drugs Price by Type (2012-2017)
4.4 United States Anti-Migraine Drugs Sales Growth Rate by Type (2012-2017)

5 United States Anti-Migraine Drugs Sales (Volume) by Application (2012-2017)
5.1 United States Anti-Migraine Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Anti-Migraine Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Anti-Migraine Drugs Players/Suppliers Profiles and Sales Data
6.1 Eli Lilly
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Anti-Migraine Drugs Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Eli Lilly Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Abbott Laboratories
6.2.2 Anti-Migraine Drugs Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Abbott Laboratories Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Eisai
6.3.2 Anti-Migraine Drugs Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Eisai Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Allergan
6.4.2 Anti-Migraine Drugs Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Allergan Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Endo
6.5.2 Anti-Migraine Drugs Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Endo Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 GlaxoSmithKline
6.6.2 Anti-Migraine Drugs Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 GlaxoSmithKline Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Impax Laboratories
6.7.2 Anti-Migraine Drugs Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Impax Laboratories Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Pfizer
6.8.2 Anti-Migraine Drugs Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Pfizer Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 AstraZeneca
6.9.2 Anti-Migraine Drugs Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 AstraZeneca Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Bayer
6.10.2 Anti-Migraine Drugs Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Bayer Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Johnson & Johnson
6.12 Merck
6.13 Teva
6.14 Allergan
6.15 Amgen

7 Anti-Migraine Drugs Manufacturing Cost Analysis
7.1 Anti-Migraine Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Anti-Migraine Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Anti-Migraine Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Anti-Migraine Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Anti-Migraine Drugs Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Anti-Migraine Drugs Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Anti-Migraine Drugs Sales Volume Forecast by Type (2017-2022)
11.3 United States Anti-Migraine Drugs Sales Volume Forecast by Application (2017-2022)
11.4 United States Anti-Migraine Drugs Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Anti-Migraine Drugs
Figure United States Anti-Migraine Drugs Market Size (K Pcs) by Type (2012-2022)
Figure United States Anti-Migraine Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Triptans Product Picture
Figure Ergots Product Picture
Figure Others Product Picture
Figure United States Anti-Migraine Drugs Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Anti-Migraine Drugs by Application in 2016
Figure Women Examples
Table Key Downstream Customer in Women
Figure Men Examples
Table Key Downstream Customer in Men
Figure United States Anti-Migraine Drugs Market Size (Million USD) by Region (2012-2022)
Figure The West Anti-Migraine Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Anti-Migraine Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Anti-Migraine Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Anti-Migraine Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Anti-Migraine Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Anti-Migraine Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Anti-Migraine Drugs Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Anti-Migraine Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Anti-Migraine Drugs Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Anti-Migraine Drugs Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Anti-Migraine Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Anti-Migraine Drugs Sales Share by Players/Suppliers
Figure 2017 United States Anti-Migraine Drugs Sales Share by Players/Suppliers
Figure United States Anti-Migraine Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Anti-Migraine Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Anti-Migraine Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Anti-Migraine Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Anti-Migraine Drugs Revenue Share by Players/Suppliers
Table United States Market Anti-Migraine Drugs Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Anti-Migraine Drugs Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Anti-Migraine Drugs Market Share of Top 3 Players/Suppliers
Figure United States Anti-Migraine Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Anti-Migraine Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Anti-Migraine Drugs Product Category
Table United States Anti-Migraine Drugs Sales (K Pcs) by Region (2012-2017)
Table United States Anti-Migraine Drugs Sales Share by Region (2012-2017)
Figure United States Anti-Migraine Drugs Sales Share by Region (2012-2017)
Figure United States Anti-Migraine Drugs Sales Market Share by Region in 2016
Table United States Anti-Migraine Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Anti-Migraine Drugs Revenue Share by Region (2012-2017)
Figure United States Anti-Migraine Drugs Revenue Market Share by Region (2012-2017)
Figure United States Anti-Migraine Drugs Revenue Market Share by Region in 2016
Table United States Anti-Migraine Drugs Price (USD/Pcs) by Region (2012-2017)
Table United States Anti-Migraine Drugs Sales (K Pcs) by Type (2012-2017)
Table United States Anti-Migraine Drugs Sales Share by Type (2012-2017)
Figure United States Anti-Migraine Drugs Sales Share by Type (2012-2017)
Figure United States Anti-Migraine Drugs Sales Market Share by Type in 2016
Table United States Anti-Migraine Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Anti-Migraine Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Anti-Migraine Drugs by Type (2012-2017)
Figure Revenue Market Share of Anti-Migraine Drugs by Type in 2016
Table United States Anti-Migraine Drugs Price (USD/Pcs) by Types (2012-2017)
Figure United States Anti-Migraine Drugs Sales Growth Rate by Type (2012-2017)
Table United States Anti-Migraine Drugs Sales (K Pcs) by Application (2012-2017)
Table United States Anti-Migraine Drugs Sales Market Share by Application (2012-2017)
Figure United States Anti-Migraine Drugs Sales Market Share by Application (2012-2017)
Figure United States Anti-Migraine Drugs Sales Market Share by Application in 2016
Table United States Anti-Migraine Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Anti-Migraine Drugs Sales Growth Rate by Application (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Anti-Migraine Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Eli Lilly Anti-Migraine Drugs Sales Growth Rate (2012-2017)
Figure Eli Lilly Anti-Migraine Drugs Sales Market Share in United States (2012-2017)
Figure Eli Lilly Anti-Migraine Drugs Revenue Market Share in United States (2012-2017)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Anti-Migraine Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Abbott Laboratories Anti-Migraine Drugs Sales Growth Rate (2012-2017)
Figure Abbott Laboratories Anti-Migraine Drugs Sales Market Share in United States (2012-2017)
Figure Abbott Laboratories Anti-Migraine Drugs Revenue Market Share in United States (2012-2017)
Table Eisai Basic Information List
Table Eisai Anti-Migraine Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Eisai Anti-Migraine Drugs Sales Growth Rate (2012-2017)
Figure Eisai Anti-Migraine Drugs Sales Market Share in United States (2012-2017)
Figure Eisai Anti-Migraine Drugs Revenue Market Share in United States (2012-2017)
Table Allergan Basic Information List
Table Allergan Anti-Migraine Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Allergan Anti-Migraine Drugs Sales Growth Rate (2012-2017)
Figure Allergan Anti-Migraine Drugs Sales Market Share in United States (2012-2017)
Figure Allergan Anti-Migraine Drugs Revenue Market Share in United States (2012-2017)
Table Endo Basic Information List
Table Endo Anti-Migraine Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Endo Anti-Migraine Drugs Sales Growth Rate (2012-2017)
Figure Endo Anti-Migraine Drugs Sales Market Share in United States (2012-2017)
Figure Endo Anti-Migraine Drugs Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Anti-Migraine Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Anti-Migraine Drugs Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Anti-Migraine Drugs Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Anti-Migraine Drugs Revenue Market Share in United States (2012-2017)
Table Impax Laboratories Basic Information List
Table Impax Laboratories Anti-Migraine Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Impax Laboratories Anti-Migraine Drugs Sales Growth Rate (2012-2017)
Figure Impax Laboratories Anti-Migraine Drugs Sales Market Share in United States (2012-2017)
Figure Impax Laboratories Anti-Migraine Drugs Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Anti-Migraine Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Anti-Migraine Drugs Sales Growth Rate (2012-2017)
Figure Pfizer Anti-Migraine Drugs Sales Market Share in United States (2012-2017)
Figure Pfizer Anti-Migraine Drugs Revenue Market Share in United States (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Anti-Migraine Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AstraZeneca Anti-Migraine Drugs Sales Growth Rate (2012-2017)
Figure AstraZeneca Anti-Migraine Drugs Sales Market Share in United States (2012-2017)
Figure AstraZeneca Anti-Migraine Drugs Revenue Market Share in United States (2012-2017)
Table Bayer Basic Information List
Table Bayer Anti-Migraine Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bayer Anti-Migraine Drugs Sales Growth Rate (2012-2017)
Figure Bayer Anti-Migraine Drugs Sales Market Share in United States (2012-2017)
Figure Bayer Anti-Migraine Drugs Revenue Market Share in United States (2012-2017)
Table Johnson & Johnson Basic Information List
Table Merck Basic Information List
Table Teva Basic Information List
Table Allergan Basic Information List
Table Amgen Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anti-Migraine Drugs
Figure Manufacturing Process Analysis of Anti-Migraine Drugs
Figure Anti-Migraine Drugs Industrial Chain Analysis
Table Raw Materials Sources of Anti-Migraine Drugs Major Players/Suppliers in 2016
Table Major Buyers of Anti-Migraine Drugs
Table Distributors/Traders List
Figure United States Anti-Migraine Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Anti-Migraine Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Anti-Migraine Drugs Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Anti-Migraine Drugs Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Anti-Migraine Drugs Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Anti-Migraine Drugs Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Anti-Migraine Drugs Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Anti-Migraine Drugs Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Anti-Migraine Drugs Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Anti-Migraine Drugs Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Anti-Migraine Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Anti-Migraine Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Anti-Migraine Drugs Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *